Cite
HARVARD Citation
Wang, X. et al. (2023). Concerns on Bebtelovimab (LY‐CoV1404) used to neutralize Omicron subvariants. Journal of medical virology. 95 (2), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, X. et al. (2023). Concerns on Bebtelovimab (LY‐CoV1404) used to neutralize Omicron subvariants. Journal of medical virology. 95 (2), p. n/a. [Online].